CA ATRA ALL TRANS RETINOIC ACID CAPSULES

Get a Price/Quote

CA ATRA ALL TRANS RETINOIC ACID CAPSULES Specification

Indication
Acute promyelocytic leukemia (APL)

Pacakaging (Quantity Per Box)
100 capsules

Salt Composition
All-Trans Retinoic Acid

Dosage Form
Oral capsule

Origin of Medicine
Allopathic

Drug Type
Prescription (Rx)

Ingredients
All-Trans Retinoic Acid (Tretinoin)

Physical Form
Capsules

Function
Anticancer, induces differentiation of promyelocytic leukemia cells

Recommended For
Treatment of acute promyelocytic leukemia (APL)

Dosage
As directed by the physician

Dosage Guidelines
Take exactly as prescribed by your oncologist

Suitable For
Adults

Quantity
Various pack sizes available

Storage Instructions
Store below 25C, protect from light and moisture

CA ATRA ALL TRANS RETINOIC ACID CAPSULES Trade Information

Packaging Details
PACK OF 100 CAPSULES

About CA ATRA ALL TRANS RETINOIC ACID CAPSULES

Ca Atra-10

Specifications:-

Brand Name: CAATRA
Content: All Trans Retinoic Acid
Strengths: 10 mg
Form : Capsule
Packing: 100 capsule
Manufactured By: Jenome Biophar

Note:- CAATRA Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug................

How CA ATRA Capsules Work

CA ATRA capsules work by promoting the differentiation and maturation of abnormal promyelocytic cells into normal white blood cells, thereby helping to treat acute promyelocytic leukemia (APL). This mechanism targets the underlying disease process and supports remission in affected patients.

Safety, Storage, and Packaging

CA ATRA capsules come in yellow oral capsules, packed in blister strips within sturdy cardboard boxes. Store the capsules below 25C, protected from light and moisture, to preserve shelf life of up to 24 months. It is important to use only under medical supervision due to specific contraindications and possible side effects.

International Approval and Regulatory Quality

CA ATRA is WHO-GMP certified and holds approval in several international markets, ensuring global standards of quality, safety, and efficacy. The product is manufactured following stringent guidelines and is suitable for distribution, supply, and trade worldwide.

FAQs of CA ATRA ALL TRANS RETINOIC ACID CAPSULES:

Q: What is CA ATRA All-Trans Retinoic Acid Capsule used for?

A: CA ATRA capsules are used for the treatment of acute promyelocytic leukemia (APL) in adults, helping induce remission by differentiating abnormal leukemia cells.

Q: How should CA ATRA capsules be taken?

A: Take CA ATRA capsules orally as prescribed by your oncologist. Do not alter dosage or discontinue without medical consultation, as correct dosing is essential for optimal benefit and safety.

Q: Who should not use CA ATRA capsules?

A: CA ATRA is contraindicated for pregnant women and individuals with known hypersensitivity to tretinoin. Inform your healthcare provider if you have allergies or are pregnant before starting treatment.

Q: What are the common side effects of CA ATRA capsules?

A: Common side effects may include headache, bone pain, skin dryness, rash, and fever. If you experience severe or persistent symptoms, notify your physician promptly.

Q: How should CA ATRA capsules be stored?

A: Keep CA ATRA capsules below 25C, protected from light and moisture, ideally inside their original blister packaging to maintain potency throughout the shelf life.

Q: Where are CA ATRA capsules manufactured and distributed?

A: CA ATRA capsules are made in India under WHO-GMP standards and are supplied internationally via approved exporters, distributors, and wholesalers.

Q: What is the benefit of using CA ATRA capsules in APL treatment?

A: CA ATRA capsules induce differentiation of promyelocytic leukemia cells into normal cells, directly addressing the disease process and improving patient outcomes.

Tell us about your requirement